Suppr超能文献

用纳米白蛋白结合型紫杉醇成功治疗合并弥散性血管内凝血的心脏血管肉瘤:1例报告并文献复习

Successful Treatment of Cardiac Angiosarcoma Associated with Disseminated Intravascular Coagulation with Nab-Paclitaxel: A Case Report and Review of the Literature.

作者信息

Honda Kazunori, Ando Masashi, Sugiyama Keiji, Mitani Seiichiro, Masuishi Toshiki, Narita Yukiya, Taniguchi Hiroya, Kadowaki Shigenori, Ura Takashi, Muro Kei

机构信息

Department of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya, Japan.

出版信息

Case Rep Oncol. 2017 Sep 21;10(3):863-870. doi: 10.1159/000481194. eCollection 2017 Sep-Dec.

Abstract

Angiosarcoma of the heart is an uncommon soft tissue sarcoma. A few cases of disseminated intravascular coagulation (DIC) associated with angiosarcoma occurring in various organs, but not the heart, have been reported. Although taxane is commonly used in the treatment of metastatic angiosarcoma, data on the efficacy of nab-paclitaxel for angiosarcoma are limited. Here, we report probably the first case of a patient with primary cardiac angiosarcoma with coexisting DIC who was successfully treated with nab-paclitaxel. A 62-year-old female with chief complaints of nausea and shortness of breath was diagnosed as having cardiac angiosarcoma with liver metastases. Four months after the resection of her primary tumor, the hepatic metastatic lesions progressed rapidly accompanied by new metastatic lesions in the right iliac bone and signs of DIC. She received nab-paclitaxel as first-line chemotherapy. A response of stable disease was achieved after 2 treatment cycles and DIC was successfully controlled for at least 4 months. This report suggests potential utility of nab-paclitaxel for angiosarcoma complicated with DIC. We also review the literature for all cases of angiosarcoma with DIC reported so far.

摘要

心脏血管肉瘤是一种罕见的软组织肉瘤。有几例发生于各种器官而非心脏的血管肉瘤伴发弥散性血管内凝血(DIC)的病例已被报道。虽然紫杉烷常用于转移性血管肉瘤的治疗,但关于纳米白蛋白结合型紫杉醇治疗血管肉瘤疗效的数据有限。在此,我们报告了可能首例原发性心脏血管肉瘤合并DIC且成功接受纳米白蛋白结合型紫杉醇治疗的患者。一名以恶心和气短为主诉的62岁女性被诊断为患有心脏血管肉瘤伴肝转移。在其原发肿瘤切除4个月后,肝转移病灶迅速进展,并伴有右髂骨新的转移病灶及DIC征象。她接受纳米白蛋白结合型紫杉醇作为一线化疗。2个治疗周期后达到疾病稳定的反应,且DIC成功控制至少4个月。本报告提示纳米白蛋白结合型紫杉醇对合并DIC的血管肉瘤具有潜在应用价值。我们还回顾了迄今报道的所有血管肉瘤合并DIC病例的文献。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d34/5649245/82ab8c6d94bd/cro-0010-0863-g01.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验